South Korea Pan-genomic And Multi-gene Panel Testing Market Size & Outlook
Related Markets
South Korea pan-genomic and multi-gene panel testing market highlights
- The South Korea pan-genomic and multi-gene panel testing market generated a revenue of USD 144.5 million in 2024 and is expected to reach USD 383.4 million by 2033.
- The South Korea market is expected to grow at a CAGR of 11.7% from 2025 to 2033.
- In terms of segment, oncology multi-gene panels was the largest revenue generating test type in 2024.
- Pan-Genomic / Whole Exome Based Panels is the most lucrative test type segment registering the fastest growth during the forecast period.
Pan-genomic and multi-gene panel testing market data book summary
| Market revenue in 2024 | USD 144.5 million |
| Market revenue in 2033 | USD 383.4 million |
| Growth rate | 11.7% (CAGR from 2025 to 2033) |
| Largest segment | Oncology multi-gene panels |
| Fastest growing segment | Pan-Genomic / Whole Exome Based Panels |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pan-Genomic / Whole Exome Based Panels, Comprehensive Hereditary Disease Panels, Oncology Multi-Gene Panels, Pharmacogenomics (PGx) Panels |
Other key industry trends
- In terms of revenue, South Korea accounted for 1.6% of the global pan-genomic and multi-gene panel testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China pan-genomic and multi-gene panel testing market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 895.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pan-genomic And Multi-gene Panel Testing Market Scope
Pan-genomic And Multi-gene Panel Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GeneDx | View profile | 501-1000 | Stamford, Connecticut, United States, North America | https://www.genedx.com |
| Caris Life Sciences | View profile | 1001-5000 | Irving, Texas, United States, North America | http://www.carislifesciences.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.foundationmedicine.com |
| Baylor Genetics | View profile | 251-500 | Houston, Texas, United States, North America | https://www.baylorgenetics.com/ |
| Ambry Genetics | View profile | 251-500 | Aliso Viejo, California, United States, North America | http://www.ambrygen.com/ |
| Fulgent Genetics Inc | View profile | 1012 | 4399 Santa Anita Avenue, El Monte, CA, United States, 91731 | https://www.fulgentgenetics.com |
| Natera Inc | View profile | 3293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | https://www.natera.com |
| Guardant Health Inc | View profile | 1779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | https://www.guardanthealth.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
South Korea pan-genomic and multi-gene panel testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pan-genomic and multi-gene panel testing market will help companies and investors design strategic landscapes.
Oncology multi-gene panels was the largest segment with a revenue share of 61.18% in 2024. Horizon Databook has segmented the South Korea pan-genomic and multi-gene panel testing market based on pan-genomic / whole exome based panels, comprehensive hereditary disease panels, oncology multi-gene panels, pharmacogenomics (pgx) panels covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to South Korea pan-genomic and multi-gene panel testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Korea pan-genomic and multi-gene panel testing market databook
-
Our clientele includes a mix of pan-genomic and multi-gene panel testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea pan-genomic and multi-gene panel testing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea pan-genomic and multi-gene panel testing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
South Korea Test Type - Pan-genomic And Multi-gene Panel Testing Market size, 2024 - 2033 (US$M)
South Korea Pan-genomic And Multi-gene Panel Testing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
